Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny
by multiple authors
Plausibility of second medical use patents: pregabalin in the Supreme Court
The grant of an SPC for a new therapeutic application
Infringement of second medical use patents in the UK: pregabalin in the Supreme Court
Cannabis: what's new for the 6000 year old medicine?
Life Sciences Organisation sets out the UK stall
Who owns editorial control over the code of life? An update on CRISPR
Tailored injunctive relief in life sciences patent cases
Biosimilars – interchangeability/substitution and advertising
by multiple authors